ADAR1 Capital Management, LLC

KROS

ADAR1 Capital Management, LLC serves as 10% Owner at Keros Therapeutics, Inc. (KROS). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

2 trades

$9.56M

Total Sells

1 trades

$95.66M

Net Position

Net Seller

$86.10M

Companies Traded

KROS, PVLA

Active Period

Aug 2024 – Oct 2025

3 total trades

Most Recent

Sell KROS

Oct 15, 2025 · $95.66M

ADAR1 Capital Management, LLC's Insider Trading at Keros Therapeutics, Inc. (KROS)

Buys

1 · $9.46M

Sells

1 · $95.66M

Total Shares Bought

934,258

Total Shares Sold

5,389,264

KROS Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Oct 15, 2025	Sell	5,389,264	$17.75	$95.66M	0
Apr 11, 2025	Buy	934,258	$10.13	$9.46M	4,392,737

ADAR1 Capital Management, LLC's Insider Trading at Palvella Therapeutics, Inc. (PVLA)

Buys

1 · $92.3K

Sells

0 · $0.00

Total Shares Bought

6,000

Total Shares Sold

PVLA Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Aug 12, 2024	Buy	6,000	$15.39	$92.3K	129,574

Related Insiders

Kathleen Goin

officer: Chief Operating Officer

PVLASell · Apr 17, 2026

BIENAIME JEAN JACQUES

director

KROSBuy · Apr 17, 2026

JENKINS GEORGE M

director

PVLABuy · Apr 1, 2026

HERON ELAINE J

director

PVLABuy · Mar 2, 2026

Jasbir Seehra

CHIEF EXECUTIVE OFFICER

KROSSell · Feb 19, 2026

Esther Cho

SVP, General Counsel

KROSSell · Feb 18, 2026

Lorena Raquel Lerner

Chief Science Officer

KROSSell · Feb 18, 2026

Keith Regnante

CHIEF FINANCIAL OFFICER

KROSSell · Feb 18, 2026

Explore More Insider Trading Data

KROS Insider Trading Activity

View all insider trades at Keros Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity